Psychiatric Disorders During Pregnancy

Beyond the NICU: The Psychological Impact of Premature Birth on Mothers

Preterm birth can increase maternal vulnerability to postpartum depression, anxiety, and PTSD. Learn how gestational age and the NICU experience affect mental health.

By |2026-11-11T14:33:48-04:00November 11th, 2026|Postpartum, Postpartum Depression, Postpartum Psychiatric Disorders, Pregnancy, Psychiatric Disorders During Pregnancy|Comments Off on Beyond the NICU: The Psychological Impact of Premature Birth on Mothers

Suicidal Ideation Across Pregnancy and the Postpartum: Recognizing Patterns Across Two Common Screening Tools

A study tracking suicidal ideation across pregnancy and postpartum identified distinct trajectories and differences between the EPDS and PHQ-9, highlighting challenges in screening.

By |2026-11-04T17:56:18-04:00November 4th, 2026|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy, Psychotherapy, Suicide, Treatment|Comments Off on Suicidal Ideation Across Pregnancy and the Postpartum: Recognizing Patterns Across Two Common Screening Tools

ADHD Medications During Pregnancy: What Does the Latest Meta-Analysis Tell Us?

A new meta-analysis examines ADHD medication use during pregnancy, finding reassuring results for most outcomes while identifying a possible small increase in cardiovascular malformations with methylphenidate.

By |2026-10-28T16:39:00-04:00October 28th, 2026|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on ADHD Medications During Pregnancy: What Does the Latest Meta-Analysis Tell Us?

A Psychedelic Treatment for Postpartum Depression? Early Findings on GH001

A small phase 2a trial of GH001, an investigational psychedelic compound, found a rapid reduction in postpartum depression symptoms. Larger studies are needed to assess safety and durability.

By |2026-10-20T15:45:03-04:00October 20th, 2026|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on A Psychedelic Treatment for Postpartum Depression? Early Findings on GH001

Beyond Screening: Supporting the Mental Health of NICU Parents

Parents of infants in the NICU face high rates of depression, anxiety, stress, and trauma. Are we doing enough to identify their needs—and provide meaningful mental health support?

A Link Between Childhood Adversity and Polycystic Ovary Syndrome

In this North American cross-sectional study, higher exposure to early life adversities was associated with a higher lifetime prevalence of physician-diagnosed PCOS/PMOS. The findings add to growing evidence that childhood adversities may have lasting effects on reproductive health.

By |2026-09-24T15:55:18-04:00September 24th, 2026|PCOS, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on A Link Between Childhood Adversity and Polycystic Ovary Syndrome

Beyond Reproductive Health: The Psychiatric Burden of Polyendocrine Metabolic Ovarian Syndrome (PMOS or PCOS)

Women with PMOS have significantly higher rates of depression and anxiety. Routine screening and integrated care are essential for improving psychiatric and reproductive outcomes.

By |2026-09-17T14:21:08-04:00September 22nd, 2026|Anxiety Disorders, Depressive Disorders, Medical Education, PCOS, Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy, Resources|Comments Off on Beyond Reproductive Health: The Psychiatric Burden of Polyendocrine Metabolic Ovarian Syndrome (PMOS or PCOS)

Essential Reads: Why All Women of Reproductive Age Should Take Folic Acid

Folic Acid Awareness Week (Sept 13-19, 2026) focuses on the importance of daily folic acid supplements for women to prevent birth defects, as diet alone is often insufficient.

By |2026-09-15T10:45:20-04:00September 15th, 2026|Medications and Pregnancy, Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on Essential Reads: Why All Women of Reproductive Age Should Take Folic Acid

Quetiapine Use During Pregnancy: What Do We Know About Reproductive Safety?

For women who require treatment with quetiapine during pregnancy, the available reproductive safety data are generally reassuring. The largest body of evidence does not suggest a meaningful increase in major congenital malformations, while metabolic effects, particularly gestational diabetes, remain an important consideration.

By |2026-09-14T16:12:12-04:00September 10th, 2026|Antipsychotic Medications, Medications and Pregnancy, Postpartum Psychiatric Disorders, Pregnancy Outcomes, PregnancyMedication, Psychiatric Disorders During Pregnancy|Comments Off on Quetiapine Use During Pregnancy: What Do We Know About Reproductive Safety?
Go to Top